Senescence is a process by which a cell ages and permanently stops dividing but does not die. During aging, the senescent cells accumulate in organs and promote tissue dysfunction leading to numerous age-related diseases like cancer. The cells go through a process of cellular senescence, which is a permanent cell cycle arrest resulting from multiple stresses.
The collaborative research group led by Professor Makoto Nakanishi of the Institute of Medical Science, The University of Tokyo (IMSUT) is published in the journal Science.
Can Blood Pressure Medication Prevent Aging?
Blood pressure medication metolazone activates mitochondrial unfolded protein response (UPRmt) process that repairs mitochondria, and promotes cell survival.
Advertisement
‘Progression of age-related diseases like cancer, diabetes, arteriosclerosis, and NASH can be suppressed by injecting GLS1 inhibitors that remove senescent cells from various tissues and organs.’
Read More..
Tweet it Now
Read More..
The researchers has identified an inhibitor of the glutamate metabolic enzyme GLS1 so that its administration selectively eliminates senescent cells from various organs and tissues in aged mice, and improves age-associated tissue dysfunction and the symptoms of obese diabetes, arteriosclerosis, and NASH (Non-alcoholic steatohepatitis).
Earlier studies have shown that genetically engineering removal of senescent cells from aged mice can delay the onset of many old age diseases like arteriosclerosis and renal damage thereby extending healthy life expectancy. However, effective drug candidates could not be identified from these studies.
![Discovering The Aging Mechanism Of Blood Cell Forming Process]( "Discovering The Aging Mechanism Of Blood Cell Forming Process")
When the aged hematopoietic stem cells of mouse were transferred into the bone marrow of young mouse, a change in the stem cell expression to that of young hematopoietic stem cells was seen.
Professor Nakanishi said, "Our results can contribute to the development of new anti-aging therapies that remove senescent cells by targeting these cells' metabolic characteristics."
In order to search for genes essential for senescent cells' survival, a new method was developed for producing purified senescent cells, which activates the p53 in the cell cycle thereby effectively inducing cellular senescence.
They identified GLS1 gene that is involved in glutamine metabolism is essential for senescent cells' survival and is a potential candidate gene.
On administration of GLS1 inhibitors to aged mice the senescent cells in various tissues and organs were removed and the aging phenomenon was improved significantly.
The results of this study are interesting and show that as the aging progresses, the motor function declines due to muscle loss, and metabolic disorders due to decrease in adipose tissue size occur.
However, when the researchers injected GLS1 inhibitors into mice suffering age-related disorders, the progression of these age-related symptoms was suppressed. Additionally GLS1 inhibitors also relieved the symptoms of obese diabetes, arteriosclerosis, and NASH.
Currently, GLS1 inhibitors are in clinical trials as effective cancer treatments. Professor Nakanishi said, "We hope that innovative anti-aging therapies and treatments for geriatric diseases will be developed that can remove senescent cells by treatment with GLS1 inhibitors."
Source: Medindia
Discovering The Aging Mechanism Of Blood Cell Forming Process
When the aged hematopoietic stem cells of mouse were transferred into the bone marrow of young mouse, a change in the stem cell expression to that of young hematopoietic stem cells was seen.
Advertisement
Professor Nakanishi said, "Our results can contribute to the development of new anti-aging therapies that remove senescent cells by targeting these cells' metabolic characteristics."
In order to search for genes essential for senescent cells' survival, a new method was developed for producing purified senescent cells, which activates the p53 in the cell cycle thereby effectively inducing cellular senescence.
They identified GLS1 gene that is involved in glutamine metabolism is essential for senescent cells' survival and is a potential candidate gene.
On administration of GLS1 inhibitors to aged mice the senescent cells in various tissues and organs were removed and the aging phenomenon was improved significantly.
The results of this study are interesting and show that as the aging progresses, the motor function declines due to muscle loss, and metabolic disorders due to decrease in adipose tissue size occur.
However, when the researchers injected GLS1 inhibitors into mice suffering age-related disorders, the progression of these age-related symptoms was suppressed. Additionally GLS1 inhibitors also relieved the symptoms of obese diabetes, arteriosclerosis, and NASH.
Currently, GLS1 inhibitors are in clinical trials as effective cancer treatments. Professor Nakanishi said, "We hope that innovative anti-aging therapies and treatments for geriatric diseases will be developed that can remove senescent cells by treatment with GLS1 inhibitors."
Source: Medindia
Pomegranate and Its Role in Anti-aging
Ruby red among fruits, pomegranate, has numerous health benefits. It also plays an important role in anti-aging because of its high antioxidant content.
Advertisement
 Top Anti Aging TipsAging is natural and irreversible but it can be slowed down. Learn how to combat aging through simple means. | Advertisement
|
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News
Scientists have developed the first humanized mouse model for a rare hereditary condition.
A recent study discovered that the placenta, rather than only the brain, is crucial in determining the genetic risk of schizophrenia.
FOXI3 gene was found to be involved in Goldenhar syndrome, one form of developmental disorder, revealed research.
Contrary to previous beliefs, genes may not be fixed and can be influenced by environmental factors and lifestyle choices, according to modern scientific research.
Gene therapy successfully tested on dogs with inherited eye disease is now poised for clinical use in humans.